{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:59:33Z","timestamp":1794646773746,"version":"4.9.1"},"reference-count":50,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Breast cancer surgery has evolved from radical procedures to increasingly individualized and less invasive approaches. This narrative review contextualizes this evolution, synthesizes current evidence supporting surgical de-escalation, and examines emerging strategies that may further reduce the need for surgery. The manuscript is based on a structured appraisal of PubMed\/MEDLINE literature and major international guidelines, prioritizing randomized trials, prospective studies, and consensus statements. Contemporary practice is characterized by progressive reduction in both breast and axillary surgery, enabled by advances in tumour biology, neoadjuvant systemic therapy, sentinel node strategies, and oncoplastic techniques. Emerging approaches\u2014including selective omission of axillary surgery, targeted axillary dissection, and investigational strategies aiming at omission of breast surgery in exceptional responders\u2014highlight a shift toward response-adapted and biology-driven care. While technological innovations such as robotic surgery and intraoperative radiotherapy may influence surgical practice, their role in true de-escalation remains limited or context-dependent. Overall, the field is moving toward minimizing surgical burden without compromising oncological safety, with future progress likely driven by improved patient selection, imaging, and integration of systemic therapy response.<\/jats:p>","DOI":"10.3390\/jcm15103778","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:27:56Z","timestamp":1778776076000},"page":"3778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Breast Cancer Surgery: Past, Present and Future\u2014A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Paolo","family":"Izzo","sequence":"first","affiliation":[{"name":"\u201cPietro Valdoni\u201d Department of Surgery, Policlinico \u201cUmberto I\u201d, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5901-2659","authenticated-orcid":false,"given":"Marcello","family":"Molle","sequence":"additional","affiliation":[{"name":"Plastic and Reconstructive Surgery Unit, Multidisciplinary Department of Medical-Surgical and Dental Specialties, Universit\u00e0 degli Studi della Campania \u201cL.Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco Di","family":"Cello","sequence":"additional","affiliation":[{"name":"General Surgery Unit, ASL Frosinone, 03100 Frosinone, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Meloni","sequence":"additional","affiliation":[{"name":"Department of Radiological, Oncological, and Anatomical Pathology Sciences, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-2954","authenticated-orcid":false,"given":"Silvia","family":"Lai","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Translational and Precision Medicine, Policlinico \u201cUmberto I\u201d, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7852-032X","authenticated-orcid":false,"given":"Luciano","family":"Izzo","sequence":"additional","affiliation":[{"name":"\u201cPietro Valdoni\u201d Department of Surgery, Policlinico \u201cUmberto I\u201d, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5694-951X","authenticated-orcid":false,"given":"Simone","family":"Sibio","sequence":"additional","affiliation":[{"name":"\u201cPietro Valdoni\u201d Department of Surgery, Policlinico \u201cUmberto I\u201d, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3059-4439","authenticated-orcid":false,"given":"Daniela","family":"Messineo","sequence":"additional","affiliation":[{"name":"Department of Radiological Sciences, Oncology and Anatomo-Pathological Science, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7330-5046","authenticated-orcid":false,"given":"Sara","family":"Izzo","sequence":"additional","affiliation":[{"name":"Plastic and Reconstructive Surgery Unit, Multidisciplinary Department of Medical-Surgical and Dental Specialties, Universit\u00e0 degli Studi della Campania \u201cL.Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society (2024). Breast Cancer Facts & Figures 2024\u20132025, American Cancer Society."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/cac2.12358","article-title":"Breast cancer: An up-to-date review and future perspectives","volume":"42","author":"Hong","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1245\/s10434-025-19065-z","article-title":"Evolution of Breast Cancer Treatment 2010\u20132023","volume":"33","author":"Day","year":"2026","journal-title":"Ann. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamasurg.2020.0322","article-title":"Deimplementation of the choosing wisely recommendations for low-value breast cancer surgery: A systematic review","volume":"155","author":"Wang","year":"2020","journal-title":"JAMA Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00000658-189407000-00075","article-title":"The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894","volume":"20","author":"Halsted","year":"1894","journal-title":"Ann. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","article-title":"Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe","volume":"2","author":"Krag","year":"1993","journal-title":"Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer","volume":"32","author":"Moran","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"34","author":"Morrow","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.48095\/ccrvch2024247","article-title":"Current trends in breast cancer surgery","volume":"103","author":"Coufal","year":"2024","journal-title":"Rozhl. Chir."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1245\/s10434-015-4738-2","article-title":"Oncoplastic breast-conserving surgery reduces mastectomy and postoperative re-excision rates","volume":"22","author":"Crown","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Banys-Paluchowski, M., K\u00fchn, T., Masannat, Y., Rubio, I., de Boniface, J., Ditsch, N., Cakmak, G.K., Karakatsanis, A., Dave, R., and Hahn, M. (2023). Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4\/iBRA-NET, NCT05559411). Cancers, 15.","DOI":"10.3390\/cancers15041173"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/jamasurg.2023.6520","article-title":"Magnetic Seed vs. Guidewire Breast Cancer Localization with Magnetic Lymph Node Detection: A Randomized Clinical Trial","volume":"159","author":"Pantiora","year":"2024","journal-title":"JAMA Surg."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Heidinger, M., and Weber, W.P. (2024). Axillary surgery for breast cancer in 2024. Cancers, 16.","DOI":"10.3390\/cancers16091623"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel Lymph Node Biopsy vs. No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO-25-00099","article-title":"Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update","volume":"43","author":"Park","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary Surgery in Breast Cancer-Primary Results of the INSEMA Trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases","volume":"390","author":"Szulkin","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: A comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41591-024-03414-8","article-title":"Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: A randomized phase 3 trial (CheckMate 7FL)","volume":"31","author":"Loi","year":"2025","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41591-024-03415-7","article-title":"Pembrolizumab and chemotherapy in high-risk, early-stage ER+\/HER2- breast cancer: A randomized phase 3 trial (KEYNOTE-756)","volume":"31","author":"Cardoso","year":"2025","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.breast.2016.10.009","article-title":"Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study","volume":"31","author":"Toesca","year":"2017","journal-title":"Breast"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0000000000005924","article-title":"Robotic versus conventional or endoscopic-assisted nipple-sparing mastectomy and immediate prosthesis breast reconstruction","volume":"279","author":"Lai","year":"2024","journal-title":"Ann. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"znad336","DOI":"10.1093\/bjs\/znad336","article-title":"Postoperative complications and surgical outcomes of robotic versus conventional nipple-sparing mastectomy in breast cancer: Meta-analysis","volume":"111","author":"Nessa","year":"2024","journal-title":"Br. J. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamasurg.2023.6999","article-title":"Safety and feasibility of single-port robotic-assisted nipple-sparing mastectomy","volume":"159","author":"Farr","year":"2024","journal-title":"JAMA Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clbc.2024.12.013","article-title":"Safety and feasibility of robotic nipple-sparing mastectomy with immediate direct-to-implant reconstruction","volume":"25","author":"Lin","year":"2025","journal-title":"Clin. Breast Cancer"},{"key":"ref_39","first-page":"217","article-title":"Use of the Da Vinci SP surgical system in robot-assisted nipple-sparing mastectomy","volume":"15","author":"Lee","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9787","DOI":"10.1245\/s10434-025-18041-x","article-title":"Early postoperative outcomes of tumescent-free single-port robot-assisted nipple-sparing mastectomy (SPROUT, KoREa-BSG 14)","volume":"32","author":"Gwark","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1245\/s10434-022-11865-x","article-title":"Surgical and oncologic outcomes of robotic and conventional nipple-sparing mastectomy with immediate reconstruction: International multicenter pooled data analysis","volume":"29","author":"Park","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_42","first-page":"180","article-title":"Consensus statement on robotic nipple-sparing mastectomy: Updated GBCC 2024\/IERBS 2024","volume":"28","author":"Toesca","year":"2025","journal-title":"J. Breast Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/tbcr-24-65","article-title":"Omission of breast surgery in exceptional responders after neoadjuvant chemotherapy\u2014What are future possibilities?","volume":"6","author":"Phang","year":"2025","journal-title":"Transl. Breast Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4048\/jbc.2023.0265","article-title":"Omission of breast surgery in predicted pathologic complete response after neoadjuvant systemic therapy: A multicenter, single-arm, non-inferiority trial","volume":"27","author":"Jung","year":"2024","journal-title":"J. Breast Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamasurg.2025.1072","article-title":"Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial","volume":"160","author":"Basik","year":"2025","journal-title":"JAMA Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","article-title":"Partial Breast Irradiation for Patients with Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline","volume":"14","author":"Shaitelman","year":"2024","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_47","first-page":"1441","article-title":"Artificial intelligence in surgical decision-making for breast cancer","volume":"17","year":"2025","journal-title":"Cancer Manag. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Javanmard, Z., Shahraki, S.Z., Safari, K., Omidi, A., Raoufi, S., Rajabi, M., Akbari, M.E., and Aria, M. (2025). Artificial intelligence in breast cancer survival prediction: A comprehensive systematic review and meta-analysis. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1420328"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer","volume":"380","author":"Huang","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(24)00054-0","article-title":"3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): A randomised, open-label, phase 2 trial","volume":"403","author":"Colleoni","year":"2024","journal-title":"Lancet"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:49:24Z","timestamp":1778777364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15103778"],"URL":"https:\/\/doi.org\/10.3390\/jcm15103778","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}